hVIVO Future Growth

Future criteria checks 1/6

hVIVO's earnings are forecast to decline at 15.2% per annum while its annual revenue is expected to grow at 4.1% per year. EPS is expected to decline by 19.1% per annum. Return on equity is forecast to be 21.2% in 3 years.

Key information

-15.2%

Earnings growth rate

-19.1%

EPS growth rate

Life Sciences earnings growth25.6%
Revenue growth rate4.1%
Future return on equity21.2%
Analyst coverage

Good

Last updated06 Oct 2024

Recent future growth updates

Recent updates

Earnings and Revenue Growth Forecasts

DB:CRO - Analysts future estimates and past financials data (GBP Millions)
DateRevenueEarningsFree Cash FlowCash from OpAvg. No. Analysts
12/31/2026731114153
12/31/2025681015177
12/31/202462910147
6/30/20246717713N/A
3/31/20246317915N/A
12/31/202359161217N/A
9/30/20236091619N/A
6/30/20236031920N/A
3/31/20235611718N/A
12/31/202251-11516N/A
9/30/202243-11011N/A
6/30/202235-157N/A
3/31/202237-134N/A
12/31/202139001N/A
9/30/202139-212N/A
6/30/202139-324N/A
3/31/202130-734N/A
12/31/202022-1134N/A
9/30/202016-11-1-1N/A
6/30/202010-11-6-5N/A
3/31/20207-8-4-4N/A
12/31/20193-6-3-3N/A
6/30/2019N/A-2-1-1N/A
3/31/2019N/A-1-1-1N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: CRO's earnings are forecast to decline over the next 3 years (-15.2% per year).

Earnings vs Market: CRO's earnings are forecast to decline over the next 3 years (-15.2% per year).

High Growth Earnings: CRO's earnings are forecast to decline over the next 3 years.

Revenue vs Market: CRO's revenue (4.1% per year) is forecast to grow slower than the German market (5.5% per year).

High Growth Revenue: CRO's revenue (4.1% per year) is forecast to grow slower than 20% per year.


Earnings per Share Growth Forecasts


Future Return on Equity

Future ROE: CRO's Return on Equity is forecast to be high in 3 years time (21.2%)


Discover growth companies